Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-23-019675

Interim CEO and President acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rodgers Richard J Interim CEO and President 2023-04-19 Grant or award +50,000 138,246 D: show line 1 in the form
Loading xslF345X04/form4.xml…